W
William Sanchez
Researcher at Mayo Clinic
Publications - 66
Citations - 3300
William Sanchez is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Liver transplantation & Transplantation. The author has an hindex of 25, co-authored 64 publications receiving 2709 citations. Previous affiliations of William Sanchez include University of Rochester.
Papers
More filters
Journal ArticleDOI
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
TL;DR: Based on meta-analysis, statin use is associated with a reduced risk of HCC, most strongly in Asian but also in Western populations, and Randomized clinical trials in populations at high risk for HCC are warranted.
Journal ArticleDOI
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
TL;DR: ADMs may modify the risk of HCC in patients with DM, especially in the Western population, however, the effect of each individual agent should be interpreted with caution owing to inherent cancer-modifying effect of the comparator group.
Journal ArticleDOI
Chemopreventive strategies in hepatocellular carcinoma
TL;DR: Several commonly prescribed medications seem promising as chemopreventive agents against HCC, including statins, antidiabetic medications and aspirin, and dietary agents such as coffee, vitamin E and fish oil as well as phytochemicals might be associated with reduced risk of HCC.
Journal ArticleDOI
Validation of a Risk Estimation of Tumor Recurrence After Transplant (RETREAT) Score for Hepatocellular Carcinoma Recurrence After Liver Transplant.
Neil Mehta,Julie K. Heimbach,Denise M. Harnois,Gonzalo Sapisochin,Jennifer L. Dodge,David D. Lee,Justin M. Burns,William Sanchez,Paul D. Greig,David R. Grant,John P. Roberts,Francis Y. Yao +11 more
TL;DR: A simple and novel prognostic score that may improve post-LT HCC surveillance strategies and help identify patients who may benefit from future adjuvant therapies is developed and validated.
Journal ArticleDOI
Combined Liver Transplantation and Gastric Sleeve Resection for Patients With Medically Complicated Obesity and End‐Stage Liver Disease
Julie K. Heimbach,Kymberly D. Watt,John J. Poterucha,N. Francisco Ziller,S. D. Cecco,Michael Charlton,J. E. Hay,Russell H. Wiesner,William Sanchez,C. B. Rosen,James M. Swain +10 more
TL;DR: Noninvasive pretransplant weight loss was achieved by a majority, though weight gain post‐LT was common, and combined LT plus sleeve gastrectomy resulted in effective weight loss and was associated with fewer post-LT metabolic complications.